본문 바로가기
KERD
논문KCI 등재

The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Purpose: To evaluate the therapeutic effect of human embryonic stem cell (hESC)-derived multipotent mesenchymal stem cells (M-MSCs) on ketamine-induced cystitis (KC) in rats. Methods: To induce KC, 10-week-old female rats were injected with 25-mg/kg ketamine hydrochloride twice weekly for 12 weeks. In the sham group, phosphate buffered saline (PBS) was injected instead of ketamine. One week after the final injection of ketamine, the indicated doses (0.25, 0.5, and 1×106 cells) of M-MSCs (KC+M-MSC group) or PBS vehicle (KC group) were directly injected into the bladder wall. One week after M-MSC injection, the therapeutic outcomes were evaluated via cystometry, histological analyses, and measurement of gene expression. Next, we compared the efficacy of M-MSCs at a low dose (1×105 cells) to that of an identical dose of adult bone marrow (BM)-derived MSCs. Results: Rats in the KC group exhibited increased voiding frequency and reduced bladder capacity compared to rats of the sham group. However, these parameters recovered after transplantation of M-MSCs at all doses tested. KC bladders exhibited markedly increased mast cell infiltration, apoptosis, and tissue fibrosis. Administration of M-MSCs significantly reversed these characteristic histological alterations. Gene expression analyses indicated that several genes associated with tissue fibrosis were markedly upregulated in KC bladders. However the expression of these genes was significantly suppressed by the administration of M-MSCs. Importantly, M-MSCs ameliorated bladder deterioration in KC rats after injection of a low dose (1×105) of cells, at which point BM-derived MSCs did not substantially improve bladder function. Conclusions: This study demonstrates for the first time the therapeutic efficacy of hESC-derived M-MSCs on KC in rats. MMSCs restored bladder function more effectively than did BM-derived MSCs, protecting against abnormal changes including mast cell infiltration, apoptosis and fibrotic damage.

Abstract

Purpose: To evaluate the therapeutic effect of human embryonic stem cell (hESC)-derived multipotent mesenchymal stem cells (M-MSCs) on ketamine-induced cystitis (KC) in rats. Methods: To induce KC, 10-week-old female rats were injected with 25-mg/kg ketamine hydrochloride twice weekly for 12 weeks. In the sham group, phosphate buffered saline (PBS) was injected instead of ketamine. One week after the final injection of ketamine, the indicated doses (0.25, 0.5, and 1×106 cells) of M-MSCs (KC+M-MSC group) or PBS vehicle (KC group) were directly injected into the bladder wall. One week after M-MSC injection, the therapeutic outcomes were evaluated via cystometry, histological analyses, and measurement of gene expression. Next, we compared the efficacy of M-MSCs at a low dose (1×105 cells) to that of an identical dose of adult bone marrow (BM)-derived MSCs. Results: Rats in the KC group exhibited increased voiding frequency and reduced bladder capacity compared to rats of the sham group. However, these parameters recovered after transplantation of M-MSCs at all doses tested. KC bladders exhibited markedly increased mast cell infiltration, apoptosis, and tissue fibrosis. Administration of M-MSCs significantly reversed these characteristic histological alterations. Gene expression analyses indicated that several genes associated with tissue fibrosis were markedly upregulated in KC bladders. However the expression of these genes was significantly suppressed by the administration of M-MSCs. Importantly, M-MSCs ameliorated bladder deterioration in KC rats after injection of a low dose (1×105) of cells, at which point BM-derived MSCs did not substantially improve bladder function. Conclusions: This study demonstrates for the first time the therapeutic efficacy of hESC-derived M-MSCs on KC in rats. MMSCs restored bladder function more effectively than did BM-derived MSCs, protecting against abnormal changes including mast cell infiltration, apoptosis and fibrotic damage.

참고문헌 (37)

  1. Bokor G, "Ketamine: an update on its abuse", J Pharm Pract, 27, pp.582~586 (2014)[DOI]
  2. Winstock AR, "The prevalence and natural history of urinary symptoms among recreational ketamine users", BJU Int, 110, pp.1762~1766 (2012)[DOI]
  3. Jhang JF, "Patient characteristics for different therapeutic strategies in the management ketamine cystitis", Neurourol Urodyn, 36, pp.687~691 (2017)[DOI]
  4. Chen IC, "Risk factors of lower urinary tract syndrome among ketamine users", Low Urin Tract Symptoms (2017)[DOI]
  5. Jhang JF, "Possible pathophysiology of ketaminerelated cystitis and associated treatment strategies", Int J Urol, 22, pp.816~825 (2015)[DOI]
  6. Chu PS, "The destruction of the lower urinary tract by ketamine abuse: a new syndrome?", BJU Int, 102, pp.1616~1622 (2008)[DOI]
  7. Lai Y, "Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity", Urol Int, 89, pp.93~96 (2012)[DOI]
  8. Jiang S, "Treatment ketamine-related bladder dysfunction by intravesical injection of botulinum toxin A", J Third Mil Med Univ, 34, pp.1120~1122 (2012)
  9. Chung SD, "Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain", Neurourol Urodyn, 33, pp.1207~1211 (2014)[DOI]
  10. Damien P, "Regenerative therapy and immune modulation using umbilical cord blood-derived cells", Biol Blood Marrow Transplant, 21, pp.1545~1554 (2015)[DOI]
  11. Lim JY, "Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis", Sci Rep, 6, pp.26851~ (2016)[DOI]
  12. Zhao W, "Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model", Eur Urol, 59, pp.155~163 (2011)[DOI]
  13. Wezel F, "Regenerative medicine in urology", BJU Int, 108, pp.1046~1065 (2011)[DOI]
  14. Gnecchi M, "Paracrine mechanisms in adult stem cell signaling and therapy", Circ Res, 103, pp.1204~1219 (2008)[DOI]
  15. Song M, "Mesenchymal stem cell therapy alleviates interstitial cystitis by activating wnt signaling pathway", Stem Cells Dev, 24, pp.1648~1657 (2015)[DOI]
  16. Kim A, "Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder", Sci Rep, 6, pp.30881~ (2016)[DOI]
  17. 김아람, "Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis", bladder pain syndrome and the efficacy of antimuscarinic treatment, 2017, pp.58(5), 353~358[DOI]
  18. Jaing TH, "Umbilical cord blood: a trustworthy source of multipotent stem cells for regenerative medicine", Cell Transplant, 23, pp.493~496 (2014)[DOI]
  19. Knaan-Shanzer S, "Concise review: the immune status of mesenchymal stem cells and its relevance for therapeutic application", Stem Cells, 32, pp.603~608 (2014)[DOI]
  20. Karlsson C, "Human embryonic stem cell-derived mesenchymal progenitors: potential in regenerative medicine", Stem Cell Res, 3, pp.39~50 (2009)[DOI]
  21. Thomson JA, "Embryonic stem cell lines derived from human blastocysts", Science, 282, pp.1145~1147 (1998)[DOI]
  22. Moon SH, "Differentiation of hESCs into mesodermal subtypes: vascular-, hematopoietic-and mesenchymal-lineage cells", Int J Stem Cells, 4, pp.24~34 (2011)[DOI]
  23. Kim JM, "Perivascular progenitor cells derived from human embryonic stem cells exhibit functional characteristics of pericytes and improve the retinal vasculature in a rodent model of diabetic retinopathy", Stem Cells Transl Med, 5, pp.1268~1276 (2016)[DOI]
  24. Hong KS, "A porous membrane-mediated isolation of mesenchymal stem cells from human embryonic stem cells", Tissue Eng Part C Methods, 21, pp.322~329 (2015)[DOI]
  25. 이택, "The Role of Intra-abdominal Pressure Measurement in Awake Rat Cystometry", International Neurourology Journal, 17(2), pp.44~47 (2013), 대한배뇨장애요실금학회[DOI]
  26. 진롱후, "Urodynamic Findings in an Awake Chemical Cystitis Rat Model Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures", International Neurourology Journal, 14(1), pp.54~60 (2010), 대한배뇨장애요실금학회
  27. Jin HJ, "Senescence-associated MCP-1 secretion is dependent on a decline in BMI1 in human mesenchymal stromal cells", Antioxid Redox Signal, 24, pp.471~485 (2016)[DOI]
  28. Heo J, "Sirt1 regulates DNA methylation and differentiation potential of embryonic stem cells by antagonizing Dnmt3l", Cell Rep, 18, pp.1930~1945 (2017)[DOI]
  29. Jeong EM, "Real-time monitoring of glutathione in living cells reveals that high glutathione levels are required to maintain stem cell function", Stem Cell Reports (2018)[DOI]
  30. Song M, "The fibrosis of ketamine, a noncompetitive N-methyl-d-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model", Drug Chem Toxicol, 39, pp.206~212 (2016)[DOI]
  31. Shen CH, "Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine injected mice", Mol Med Rep, 11, pp.887~895 (2015)[DOI]
  32. Gu D, "Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system", Int J Urol, 20, pp.1024~1031 (2013)
  33. Rajandram R, "Intact urothelial barrier function in a mouse model of ketamineinduced voiding dysfunction", Am J Physiol Renal Physiol, 310, pp.F885~F894 (2016)[DOI]
  34. Kim A, "Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome", Sci Rep, 7, pp.8872~ (2017)[DOI]
  35. Janicki TI, "Chronic pelvic pain as a form of complex regional pain syndrome", Clin Obstet Gynecol, 46, pp.797~803 (2003)[DOI]
  36. Rosen JM, "Mechanisms of pain from urinary tract infection", Int J Urol, 21(Suppl 1), pp.26~32 (2014)[DOI]
  37. Barrot M, "Tests and models of nociception and pain in rodents", Neuroscience, 211, pp.39~50 (2012)[DOI]

관련 논문AI추천

Histological Examination of Engineered Mesenchymal Stem Cells Improve Bladder Function in Rat조은경, Seung Hwan Jeon대한임상검사과학회 · 대한임상검사과학회지2020 · 제52권 제2호Pre-Clinical Efficacy and Safety Evaluation of Human Amniotic Fluid-Derived Stem Cell Injection in a Mouse Model of Urinary Incontinence권태균, 김범수, 김현태, 손윤희, 송필현, 유은상, 윤석중, 임정옥, 전소영, 정성광, 최재영, James J Yoo연세대학교의과대학 · Yonsei Medical Journal2015 · 제56권 제3호New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome김아람, 송권우, 조쌍구, 아브달아메드, Soobin Lee생화학분자생물학회 · BMB Reports2022 · 제55권 제5호Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic ReviewFariba Pashazadeh, Hanieh Salehi-Pourmehr, Javad Mahmoudi, Narjes Maasoumi, Reza Rahbarghazi, Saeed Sadigh-Eteghad, Sakineh Hajebrahimi대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제3호Transplantation of Brain-Derived Neurotrophic Factor-Expressing Mesenchymal Stem Cells Improves Lower Urinary Tract Symptoms in a Rat Model박미영, Seung Hwan Jeon대한임상검사과학회 · 대한임상검사과학회지2020 · 제52권 제4호New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock WaveChih-Chieh Lin, Wei-Chia Lee, Yao-Chi Chuang, Yun-Ching Huang대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제3호

이 간행물의 다른 논문 (29건)